DOXERCALCIFEROL

DOXERCALCIFEROL was reported 167 times

DOXERCALCIFEROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANEL-REACTIVE ANTIBODY 1 0.1111
1 BROWN TUMOUR 1 0.0200
2 ATRIOVENTRICULAR BLOCK THIRD DEGREE 1 0.0104
3 SECONDARY HYPERTHYROIDISM 1 0.0103
4 HYPERVITAMINOSIS D 1 0.0083
5 RECTAL LESION 1 0.0064
6 ACID FAST BACILLI INFECTION 1 0.0062
7 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
8 PICA 1 0.0056
9 SKIN FIBROSIS 2 0.0041
10 PARATHYROID TUMOUR 1 0.0036
11 AGONAL RESPIRATION 1 0.0035
12 COLON INJURY 2 0.0035
13 VAGINAL LESION 1 0.0033
14 RENAL HYPERTENSION 1 0.0032
15 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
16 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
17 PORPHYRIA 1 0.0026
18 SKIN NODULE 1 0.0025
19 URINARY TRACT INFECTION STAPHYLOCOCCAL 1 0.0023
20 HELPLESSNESS 1 0.0021
21 ARTERIOVENOUS FISTULA 1 0.0020
22 HYPERPARATHYROIDISM SECONDARY 5 0.0020
23 PULSE PRESSURE DECREASED 1 0.0020
24 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0019
25 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
26 NAIL DYSTROPHY 1 0.0018
27 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
28 BLOOD PARATHYROID HORMONE ABNORMAL 1 0.0016
29 EXTREMITY CONTRACTURE 1 0.0016
30 AUTOIMMUNE COLITIS 1 0.0016
31 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.0015
32 SKIN HYPERTROPHY 4 0.0014
33 GRAFT LOSS 1 0.0014
34 ESCHAR 1 0.0014
35 NEPHROGENIC SYSTEMIC FIBROSIS 4 0.0013
36 NEPHROGENIC ANAEMIA 6 0.0013
37 PERITONEAL DIALYSIS 1 0.0012
38 BLOOD PHOSPHORUS INCREASED 3 0.0011
39 FOAMING AT MOUTH 2 0.0010
40 HYPERPARATHYROIDISM 2 0.0010
41 SKIN INDURATION 2 0.0010
42 OPEN WOUND 1 0.0009
43 FOLATE DEFICIENCY 1 0.0009
44 RENAL ATROPHY 1 0.0008
45 CARBON DIOXIDE INCREASED 1 0.0007
46 RENAL ARTERY STENOSIS 1 0.0007
47 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
48 REBOUND ACID HYPERSECRETION 2 0.0007
49 ORAL MUCOSAL ERUPTION 1 0.0007
50 SKIN TIGHTNESS 3 0.0006
51 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
52 END STAGE RENAL DISEASE 11 0.0006
53 EROSIVE OESOPHAGITIS 1 0.0006
54 WOUND SECRETION 2 0.0005
55 SUDDEN HEARING LOSS 1 0.0005
56 HAEMODIALYSIS 4 0.0005
57 HYPERPHOSPHATAEMIA 1 0.0005
58 CALCINOSIS 1 0.0004
59 PULSE ABNORMAL 1 0.0004
60 SUFFOCATION FEELING 1 0.0004
61 BLOOD CHLORIDE DECREASED 1 0.0004
62 LUNG CONSOLIDATION 1 0.0004
63 DRUG TOLERANCE DECREASED 1 0.0004
64 DIALYSIS 5 0.0004
65 BLOOD CULTURE POSITIVE 1 0.0003
66 METABOLIC ENCEPHALOPATHY 1 0.0003
67 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
68 FIBROSIS 1 0.0003
69 FLANK PAIN 3 0.0003
70 UNRESPONSIVE TO STIMULI 8 0.0003
71 BACTERIAL SEPSIS 1 0.0003
72 APLASIA PURE RED CELL 1 0.0003
73 DIFFICULTY IN WALKING 1 0.0003
74 AORTIC STENOSIS 1 0.0003
75 BONE LESION 1 0.0003
76 RENAL TRANSPLANT 1 0.0003
77 BLOOD PHOSPHORUS DECREASED 1 0.0003
78 HEPATIC NECROSIS 1 0.0003
79 CHEMOTHERAPY 1 0.0003
80 BLOOD MAGNESIUM DECREASED 2 0.0002
81 IMPLANT SITE PAIN 1 0.0002
82 LUPUS-LIKE SYNDROME 2 0.0002
83 LOCALISED OEDEMA 1 0.0002
84 PULSE ABSENT 1 0.0002
85 KIDNEY TRANSPLANT REJECTION 1 0.0002
86 ENTEROCOCCAL INFECTION 1 0.0002
87 ECONOMIC PROBLEM 3 0.0002
88 PERIPHERAL VASCULAR DISORDER 1 0.0002
89 APLASTIC ANAEMIA 1 0.0002
90 STEVENS-JOHNSON SYNDROME 4 0.0002
91 BLOOD CALCIUM DECREASED 2 0.0002
92 CARDIAC VALVE DISEASE 1 0.0002
93 PIGMENTATION DISORDER 1 0.0002
94 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
95 HAEMATOCRIT DECREASED 3 0.0002
96 EYE MOVEMENT DISORDER 1 0.0001
97 NEPHROTIC SYNDROME 1 0.0001
98 ECCHYMOSIS 1 0.0001
99 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
100 RESPIRATION ABNORMAL 1 0.0001
101 HAIR GROWTH ABNORMAL 1 0.0001
102 DERMATITIS BULLOUS 1 0.0001
103 ORAL DISORDER 1 0.0001
104 BREAST TENDERNESS 1 0.0001
105 CHRONIC KIDNEY DISEASE 10 0.0001
106 LIPASE INCREASED 1 0.0001
107 RENAL FAILURE CHRONIC 1 0.0001
108 PERICARDIAL EFFUSION 3 0.0001
109 BLOOD ALBUMIN DECREASED 1 0.0001
110 TRICUSPID VALVE INCOMPETENCE 1 0.0001
111 SKIN PLAQUE 1 0.0001
112 PSEUDOMONAS INFECTION 1 0.0001
113 SKIN HYPERPIGMENTATION 1 0.0001
114 PYELONEPHRITIS 1 0.0001
115 ANHEDONIA 3 0.0001
116 BLOOD CALCIUM INCREASED 1 0.0001
117 PURPURA 1 0.0001
118 BONE DISORDER 2 0.0001
119 UROSEPSIS 1 0.0001
120 HEPATIC ENCEPHALOPATHY 1 0.0001
121 DEFORMITY 1 0.0001
122 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
123 HYPOCALCAEMIA 2 0.0001
124 SPUTUM DISCOLOURED 1 0.0001
125 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
126 HYPERCHOLESTEROLAEMIA 1 0.0001
127 ATELECTASIS 1 0.0001
128 SKIN FISSURES 2 0.0001
129 RENAL TUBULAR NECROSIS 1 0.0001
130 RENAL INJURY 3 0.0001
131 INABILITY TO AFFORD MEDICATION 1 0.0001
132 BLOOD PRESSURE ABNORMAL 2 0.0001
133 BODY TEMPERATURE INCREASED 2 0.0001
134 NEUTROPHIL COUNT INCREASED 1 0.0001
135 THERAPY CESSATION 5 0.0001
136 PERITONITIS 2 0.0001
137 CARDIO-RESPIRATORY ARREST 4 0.0001
138 TRANSFUSION 1 0.0001
139 DECREASED ACTIVITY 1 0.0001
140 OESOPHAGITIS 1 0.0001
141 BLOOD GLUCOSE FLUCTUATION 1 0.0001
142 RENAL FAILURE 12 0.0001
143 VENTRICULAR FIBRILLATION 1 0.0001
144 VASCULITIS 1 0.0001
145 HYPERKALAEMIA 3 0.0001
146 SPLENOMEGALY 1 0.0001
147 CARDIOMEGALY 1 0.0001
148 HYPERCALCAEMIA 1 0.0001
149 ACUTE KIDNEY INJURY 12 0.0001
150 ANOREXIA 1 0.0001
151 SKIN ULCER 2 0.0001
152 RASH GENERALISED 2 0.0001
153 JOINT STIFFNESS 2 0.0001
154 ORAL CANDIDIASIS 1 0.0001
155 PULMONARY CONGESTION 1 0.0001
156 JOINT RANGE OF MOTION DECREASED 1 0.0001
157 QUALITY OF LIFE DECREASED 1 0.0001
158 SKIN LESION 2 0.0001
159 PERIPHERAL COLDNESS 1 0.0001
160 RESPIRATORY ARREST 2 0.0001
161 MENTAL STATUS CHANGES 2 0.0001
162 SINUS TACHYCARDIA 1 0.0001
163 SUBDURAL HAEMATOMA 1 0.0001
164 CARDIOGENIC SHOCK 1 0.0001
165 GASTROENTERITIS 1 0.0001
166 DEVICE FAILURE 1 0.0001
167 INSURANCE ISSUE 1 0.0001
168 CYANOSIS 1 0.0001
169 METABOLIC ACIDOSIS 2 0.0001
170 BLOOD CREATININE INCREASED 4 0.0001
171 SCAR 1 0.0001
172 MULTI-ORGAN FAILURE 1 0.0001
173 LYMPHOCYTE COUNT DECREASED 1 0.0001
174 HEAD DISCOMFORT 1 0.0001
175 THIRST 1 0.0001
176 GOUT 1 0.0001
177 OSTEOMYELITIS 1 0.0001
178 MEDICATION ERROR 3 0.0001
179 EYE SWELLING 2 0.0001
180 DYSPNOEA EXERTIONAL 2 0.0001
181 GASTRIC ULCER 1 0.0001
182 PROTEINURIA 1 0.0001
183 ACUTE RESPIRATORY FAILURE 1 0.0001
184 GLAUCOMA 1 0.0001
185 HAEMORRHOIDS 1 0.0001
186 INTENTIONAL SELF-INJURY 1 0.0000
187 FEELING HOT 3 0.0000
188 PULMONARY HYPERTENSION 1 0.0000
189 DERMATITIS 1 0.0000
190 RENAL FAILURE ACUTE 2 0.0000
191 FAECES DISCOLOURED 1 0.0000
192 SWELLING FACE 3 0.0000
193 MELAENA 1 0.0000
194 BLOOD PRESSURE DECREASED 3 0.0000
195 RASH PAPULAR 1 0.0000
196 LOCALISED INFECTION 1 0.0000
197 OEDEMA PERIPHERAL 5 0.0000
198 CEREBRAL INFARCTION 1 0.0000
199 ABASIA 1 0.0000
200 ABDOMINAL PAIN LOWER 1 0.0000
201 HAEMATEMESIS 1 0.0000
202 BLOOD PRESSURE INCREASED 6 0.0000
203 HAEMOGLOBIN DECREASED 4 0.0000
204 CHEST PAIN 7 0.0000
205 LIMB INJURY 1 0.0000
206 HAEMOPTYSIS 1 0.0000
207 SKIN EXFOLIATION 3 0.0000
208 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
209 RED BLOOD CELL COUNT DECREASED 1 0.0000
210 ANGINA PECTORIS 1 0.0000
211 LIVER FUNCTION TEST ABNORMAL 1 0.0000
212 TACHYCARDIA 3 0.0000
213 LACRIMATION INCREASED 1 0.0000
214 EMOTIONAL DISTRESS 4 0.0000
215 CORONARY ARTERY DISEASE 1 0.0000
216 THERAPEUTIC RESPONSE DECREASED 2 0.0000
217 DRUG ADMINISTRATION ERROR 1 0.0000
218 SWOLLEN TONGUE 1 0.0000
219 HIP FRACTURE 1 0.0000
220 HYPERHIDROSIS 4 0.0000
221 NIGHT SWEATS 1 0.0000
222 DEEP VEIN THROMBOSIS 2 0.0000
223 CHOLELITHIASIS 1 0.0000
224 STAPHYLOCOCCAL INFECTION 1 0.0000
225 LIP SWELLING 1 0.0000
226 DEHYDRATION 4 0.0000
227 CHEST DISCOMFORT 3 0.0000
228 RASH MACULAR 1 0.0000
229 HYPOXIA 1 0.0000
230 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
231 ANXIETY 8 0.0000
232 MOBILITY DECREASED 2 0.0000
233 CRYING 1 0.0000
234 RESPIRATORY FAILURE 2 0.0000
235 RESTLESSNESS 1 0.0000
236 DYSURIA 1 0.0000
237 BRONCHITIS 2 0.0000
238 COLITIS 1 0.0000
239 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
240 PLASMA CELL MYELOMA 1 0.0000
241 PALPITATIONS 3 0.0000
242 CHILLS 3 0.0000
243 CARDIAC FAILURE CONGESTIVE 2 0.0000
244 THROMBOSIS 2 0.0000
245 JOINT SWELLING 3 0.0000
246 BLINDNESS 1 0.0000
247 CARDIAC ARREST 2 0.0000
248 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
249 URINARY TRACT INFECTION 4 0.0000
250 VOMITING 11 0.0000
251 RECTAL HAEMORRHAGE 1 0.0000
252 SEPTIC SHOCK 1 0.0000
253 DYSPNOEA 13 0.0000
254 MUSCULOSKELETAL STIFFNESS 2 0.0000
255 ANGIOEDEMA 1 0.0000
256 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
257 SKIN DISCOLOURATION 1 0.0000
258 HYPOKALAEMIA 1 0.0000
259 RENAL DISORDER 1 0.0000
260 ASTHENIA 8 0.0000
261 COMA 1 0.0000
262 ANAEMIA 4 0.0000
263 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
264 CELLULITIS 1 0.0000
265 FLUSHING 2 0.0000
266 HOSPITALISATION 3 0.0000
267 NERVOUSNESS 1 0.0000
268 PANCREATITIS 1 0.0000
269 BRADYCARDIA 1 0.0000
270 PLATELET COUNT DECREASED 2 0.0000
271 PNEUMONIA 6 0.0000
272 RASH PRURITIC 1 0.0000
273 OEDEMA 1 0.0000
274 HAEMATOCHEZIA 1 0.0000
275 ANAPHYLACTIC REACTION 1 0.0000
276 ARTHROPATHY 1 0.0000
277 SEPSIS 2 0.0000
278 URTICARIA 3 0.0000
279 PANCYTOPENIA 1 0.0000
280 NECK PAIN 1 0.0000
281 BLISTER 1 0.0000
282 HYPONATRAEMIA 1 0.0000
283 MUSCULAR WEAKNESS 2 0.0000
284 LETHARGY 1 0.0000
285 ABDOMINAL PAIN 4 0.0000
286 BONE PAIN 1 0.0000
287 WHEEZING 1 0.0000
288 CATARACT 1 0.0000
289 STOMATITIS 1 0.0000
290 PLEURAL EFFUSION 1 0.0000
291 MALAISE 7 0.0000
292 PRURITUS 6 0.0000
293 FATIGUE 12 0.0000
294 AMNESIA 1 0.0000
295 INFUSION RELATED REACTION 1 0.0000
296 HYPOTENSION 3 0.0000
297 PAIN 9 0.0000
298 INJECTION SITE REACTION 1 0.0000
299 BURNING SENSATION 1 0.0000
300 INJURY 1 0.0000
301 THERAPY INTERRUPTED 1 0.0000
302 AGITATION 1 0.0000
303 PAIN IN EXTREMITY 4 0.0000
304 DYSGEUSIA 1 0.0000
305 HYPOAESTHESIA 2 0.0000
306 HALLUCINATION 1 0.0000
307 ACNE 1 0.0000
308 DEPRESSION 3 0.0000
309 CONDITION AGGRAVATED 4 0.0000
310 PARAESTHESIA 2 0.0000
311 INJECTION SITE BRUISING 1 0.0000
312 INJECTION SITE HAEMORRHAGE 1 0.0000
313 CARDIAC FAILURE 1 0.0000
314 PROSTATE CANCER 1 0.0000
315 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
316 DIARRHOEA 8 0.0000
317 CONFUSIONAL STATE 2 0.0000
318 DRY MOUTH 1 0.0000
319 INFLUENZA LIKE ILLNESS 1 0.0000
320 ABDOMINAL DISCOMFORT 2 0.0000
321 RENAL IMPAIRMENT 1 0.0000
322 MYALGIA 2 0.0000
323 MYOCARDIAL INFARCTION 2 0.0000
324 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
325 NAUSEA 9 0.0000
326 ADVERSE DRUG REACTION 1 0.0000
327 SUICIDAL IDEATION 1 0.0000
328 MUSCLE SPASMS 2 0.0000
329 HYPERSENSITIVITY 2 0.0000
330 COUGH 3 0.0000
331 BLOOD GLUCOSE INCREASED 2 0.0000
332 PULMONARY EMBOLISM 1 0.0000
333 GAIT DISTURBANCE 2 0.0000
334 DRUG INTOLERANCE 1 0.0000
335 ATRIAL FIBRILLATION 1 0.0000
336 DYSPEPSIA 1 0.0000
337 HEART RATE INCREASED 1 0.0000
338 HAEMORRHAGE 1 0.0000
339 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
340 CONSTIPATION 2 0.0000
341 FALL 3 0.0000
342 THROMBOCYTOPENIA 1 0.0000
343 PYREXIA 3 0.0000
344 BACK PAIN 2 0.0000
345 FEELING ABNORMAL 2 0.0000
346 VISION BLURRED 1 0.0000
347 ARTHRALGIA 3 0.0000
348 PERIPHERAL SWELLING 1 0.0000
349 CEREBROVASCULAR ACCIDENT 1 0.0000
350 DEATH 5 0.0000
351 OFF LABEL USE 5 0.0000
352 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
353 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
354 ERYTHEMA 1 0.0000
355 DECREASED APPETITE 1 0.0000
356 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
357 DIZZINESS 2 0.0000
358 INSOMNIA 1 0.0000
359 WEIGHT DECREASED 1 0.0000
360 RASH 1 0.0000
361 DRUG INEFFECTIVE 3 0.0000
362 HEADACHE 1 0.0000